XMD17-109
CAS No. 1435488-37-1
XMD17-109 ( ERK5-IN-1 )
产品货号. M11852 CAS No. 1435488-37-1
XMD17-109 是一种新型、特异性 ERK-5 抑制剂,在 HEK293 细胞中的 EC50 为 4.2 uM。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥434 | 有现货 |
|
| 5MG | ¥787 | 有现货 |
|
| 10MG | ¥1416 | 有现货 |
|
| 25MG | ¥2344 | 有现货 |
|
| 50MG | ¥3497 | 有现货 |
|
| 100MG | ¥4842 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥1102 | 有现货 |
|
生物学信息
-
产品名称XMD17-109
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述XMD17-109 是一种新型、特异性 ERK-5 抑制剂,在 HEK293 细胞中的 EC50 为 4.2 uM。
-
产品描述XMD17-109 is a novel, specific ERK-5 inhibitor with an EC50 4.2 uM in HEK293 cells.
-
体外实验XMD17-109 (Compound 26) inhibits ERK5 biochemically with an IC50 of 0.162 ± 0.006 μM, and blocks pidermal growth factor induced ERK5 autophosphorylation with an EC50 of 0.09 ± 0.03 μM in cells. XMD17-109 also inhibits LRRK2[G2019S] with an IC50 of 339 nM. XMD17-109 demonstrats low nanomolar cellular activity judged by the significant dose-dependent reduction of mobility shifted phosphorylated ERK5 bands from sorbitol stimulated cells. XMD17-109 completely inhibits the ERK5-mediated AP1 transcriptional activity at 30 μM and has an EC50 of 4.2 μM.
-
体内实验——
-
同义词ERK5-IN-1
-
通路MAPK/ERK Signaling
-
靶点ERK
-
受体ERK5
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number1435488-37-1
-
分子量638.81
-
分子式C36H46N8O3
-
纯度>98% (HPLC)
-
溶解度Ethanol: 100 mg/mL (156.54 mM); DMSO: 100 mg/mL (156.54 mM)
-
SMILESCN1CCN(C2CCN(C(C3=CC(OCC)=C(NC4=NC=C5C(N(C6CCCC6)C(C=CC=C7)=C7C(N5C)=O)=N4)C=C3)=O)CC2)CC1
-
化学全称11-cyclopentyl-2-((2-ethoxy-4-(4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl)phenyl)amino)-5-methyl-5,11-dihydro-6H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6-one
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Denq X, et al. Eur J Med Chem. 2013, 70, 758-767.
021-51111890
购物车()
sales@molnova.cn

